✦ LIBER ✦

PNL8 ASSESSING THE COST-EFFECTIVENESS OF IMMUNOMODULATORYTHERAPIES FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS BASED ON LONG-TERM DATA

✍ Scribed by CF Bell; JB Graham; SR Earnshaw; M Oleen-Burkey; J Castelli-Haley; KP Johnson

Book ID: 119595432
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 63 KB
Volume: 9
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)64557-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Cost Effectiveness of Interfer

Long-Term Cost Effectiveness of Interferon-β-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis

✍ Claude Lepen, Patricia Coyle, Timothy Vollmer, Lance Blumhardtf, Hervé Lilliu, D 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 145 KB

PND36 Cost-Effectiveness of Different In

PND36 Cost-Effectiveness of Different Interferon-Beta Therapies for Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Markov Model Based on Long-Term Clinical Data

✍ Nikfar, S.; Akbarisari, A.; Kebriaee, A.; Dinarvand, R.; Abdollahi, M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Cost-effectiveness of different interfer

Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments

✍ Shekoufeh Nikfar, Abbas Kebriaeezadeh… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 287 KB

Cost-Effectiveness of Glatiramer Acetate

Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study

✍ Darba, J.; Kaskens, L.; Sánchez-de la, R.osa R 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost-effectiveness of glatiramer acetate

Cost-effectiveness of glatiramer acetate and interferon beta-1a for relapsing-remitting multiple sclerosis, based on the CombiRx study

✍ Darbà, Josep; Kaskens, Lisette; Sánchez-de la Rosa, Rainel 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 206 KB

PND6 COST-EFFECTIVENESS OF GLATIRAMER AC

PND6 COST-EFFECTIVENESS OF GLATIRAMER ACETATE AND NATALIZUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN THE PRESENCE OF LONG-TERM CLINICAL EVIDENCE

✍ JB Graham; SR Earnshaw; J Castelli-Haley; M Oleen-Burkey; KP Johnson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB